Overview

Dexmedetomidine for Catheter-related Bladder Discomfort

Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- Patients scheduled for transurethral bladder resection

- ASA I-III

Exclusion Criteria:

- Patient who disagrees to participate this investigation

- Patient with severe cardiovascular disease

- Patient with small-sized foley catheter (less than 18 Fr.)

- Patinets with any urinary tract obstructions

- Patient with hyperactive or neurogenic bladder

- Patients with chronic renal failure

- Patient with morbidly obese

- Patients with neurogenic disorder

- Patient with medications for chronic pain